Kestra Medical Technologies, Ltd. Share Price

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 16/01/2026 am IST			5-day change	1st Jan Change
22.98 ^USD	+2.96%		-13.77%	-13.35%

14/01	Kestra Medical Technologies, Ltd. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 02:15 PM
13/01	Kestra Medical Technologies to Invest $5 Million in Biobeat Technologies, Incorporate Diagnostic Partnership	MT

Capitalization	134.09Cr 115.5Cr 107.64Cr 100.14Cr 186.29Cr 12TCr 199.84Cr 1.24TCr 486.65Cr 5.79TCr 502.8Cr 492.51Cr 21TCr	P/E ratio 2026 *	-9.97x	P/E ratio 2027 *	-10.9x
Enterprise value	111.62Cr 96Cr 90Cr 83Cr 155.09Cr 10TCr 166.37Cr 1.03TCr 405.13Cr 4.82TCr 418.57Cr 410.01Cr 18TCr	EV / Sales 2026 *	12.3x	EV / Sales 2027 *	9.09x
Free-Float	-	Yield 2026 *	-	Yield 2027 *	-

Timeframe

Style

14/01	Kestra Medical Technologies, Ltd. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 02:15 PM
13/01	Kestra Medical Technologies to Invest $5 Million in Biobeat Technologies, Incorporate Diagnostic Partnership	MT
01/01	Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing	MT
01/01	Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing	MT
30/12	Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors	CI
12/12	Kestra Medical Technologies, Ltd., Q2 2026 Earnings Call, Dec 11, 2025
12/12	Kestra Medical Technologies, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025	CI
12/12	Kestra Medical Fiscal Q2 Loss Narrows, Revenue Rises; Fiscal 2026 Revenue Outlook Lifted	MT
12/12	(KMTS) Kestra Medical Technologies Now Expects Full Year 2026 Revenue $91M, vs. FactSet Est of $88.1M	MT
12/12	Earnings Flash (KMTS) Kestra Medical Technologies Posts Q2 Loss $0.64, vs. FactSet Est of $0.59 Loss	MT
12/12	Earnings Flash (KMTS) Kestra Medical Technologies, Ltd. Reports Q2 Revenue $22.6M, vs. FactSet Est of $20.7M	MT
12/12	Kestra Medical Technologies, Ltd. Revises Earnings Guidance for the Fiscal Year 2026	CI
03/12	Kestra Medical Technologies Prices Upsized Offering of 6 Million Shares	MT

14/01

18/11	BTIG Research Initiates Coverage on Kestra Medical Technologies With Buy Rating, $32 Price Target	MT
31/25/31	Goldman Sachs Initiates Kestra Medical Technologies at Neutral With $24 Price Target	MT
31/25/31	BofA Securities Initiates Coverage on Kestra Medical Technologies With Buy Rating, $30 Price Target	MT
31/25/31	Stifel Initiates Kestra Medical Technologies at Buy With $28 Price Target	MT
31/25/31	Piper Sandler Initiates Kestra Medical Technologies at Overweight With $27 Price Target	MT

13/01	Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery	AQ
30/12	Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference	AQ
12/12	Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results	AQ
03/12	Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results	AQ
03/12	Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
KESTRA MEDICAL TECHNOLOGIES, LTD.	+2.96%	-13.77%	-	-	130.24Cr
IRHYTHM HOLDINGS, INC.	+5.39%	-9.09%	+66.77%	+69.01%	525.95Cr
CERIBELL, INC.	-0.39%	-1.00%	+14.03%	-	85Cr
DELTEX MEDICAL GROUP PLC	+3,074.67%	-.--%	+3,073.33%	+1,090.00%	18Cr
MEDIANA CO.,LTD	+11.71%	+15.40%	+199.19%	+168.56%	17Cr
EKF DIAGNOSTICS HOLDINGS PLC	+5.93%	+1.52%	+1.71%	-44.11%	15Cr
Average	+516.71%	-3.21%	+671.01%	+320.87%	131.77Cr
Weighted average by Cap.	+74.61%	-8.33%	+144.06%	+101.03%

	2026 *	2027 *
Net sales	9.09Cr 7.83Cr 7.3Cr 6.79Cr 13Cr 821.64Cr 14Cr 84Cr 33Cr 392.8Cr 34Cr 33Cr 1.44TCr	13Cr 12Cr 11Cr 9.98Cr 19Cr 1.21TCr 20Cr 123.24Cr 48Cr 577.13Cr 50Cr 49Cr 2.12TCr
Net income	-12Cr -11Cr -10Cr -9.31Cr -17Cr -1.13TCr -19Cr -114.95Cr -45Cr -538.3Cr -47Cr -46Cr -1.97TCr	-12Cr -10Cr -9.78Cr -9.1Cr -17Cr -1.1TCr -18Cr -112.36Cr -44Cr -526.2Cr -46Cr -45Cr -1.93TCr
Net Debt	-22Cr -19Cr -18Cr -17Cr -31Cr -2.03TCr -33Cr -207.17Cr -82Cr -970.2Cr -84Cr -83Cr -3.56TCr	-13Cr -11Cr -10Cr -9.43Cr -18Cr -1.14TCr -19Cr -116.5Cr -46Cr -545.57Cr -47Cr -46Cr -2TCr